IGM Biosciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IGMS and other ETFs, options, and stocks.

About IGMS

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM antibodies and to allow for the rapid development of engineered therapeutic antibodies.

CEO

Mary Beth Harler

CEOMary Beth Harler

Employees

149

Employees149

Headquarters

Mountain View, California

HeadquartersMountain View, California

Founded

2010

Founded2010

Employees

149

Employees149

IGMS Key Statistics

Market cap

70.94M

Market cap70.94M

Price-Earnings ratio

-0.36

Price-Earnings ratio-0.36

Dividend yield

—

Dividend yield—

Average volume

142.36K

Average volume142.36K

High today

$1.20

High today$1.20

Low today

$1.12

Low today$1.12

Open price

$1.15

Open price$1.15

Volume

102.67K

Volume102.67K

52 Week high

$22.50

52 Week high$22.50

52 Week low

$0.92

52 Week low$0.92

People also own

Based on the portfolios of people who own IGMS. This list is generated using Robinhood data, and it’s not a recommendation.